Nisa Investment Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-23,002
| Closed | -$362K | – | 2994 |
|
|
2024
Q1 | $362K | Buy |
23,002
+62
| +0.3% | +$954 | ﹤0.01% | 1176 |
|
|
2023
Q4 | $370K | Sell |
22,940
-2,300
| -9% | -$29.3K | ﹤0.01% | 1134 |
|
|
2023
Q3 | $321K | Buy |
25,240
+4
| +0% | +$55 | ﹤0.01% | 1194 |
|
|
2023
Q2 | $355K | Buy |
25,236
+566
| +2% | +$8.1K | ﹤0.01% | 1167 |
|
|
2023
Q1 | $381K | Sell |
24,670
-1,748
| -7% | -$29.2K | ﹤0.01% | 1141 |
|
|
2022
Q4 | $433K | Hold |
26,418
| – | – | ﹤0.01% | 1156 |
|
|
2022
Q3 | $479K | Buy |
26,418
+38
| +0.1% | +$596 | ﹤0.01% | 1051 |
|
|
2022
Q2 | $347K | Hold |
26,380
| – | – | ﹤0.01% | 1168 |
|
|
2022
Q1 | $245K | Sell |
26,380
-5,312
| -17% | -$45.2K | ﹤0.01% | 1301 |
|
|
2021
Q4 | $267K | Buy |
31,692
+30,112
| +1,906% | +$566K | ﹤0.01% | 1187 |
|
|
2021
Q3 | $54 | Hold |
1,580
| – | – | ﹤0.01% | 1919 |
|
|
2021
Q2 | $58 | Sell |
1,580
-50
| -3% | -$1.94K | ﹤0.01% | 1896 |
|
|
2021
Q1 | $73 | Hold |
1,630
| – | – | ﹤0.01% | 1888 |
|
|
2020
Q4 | $93K | Buy |
1,630
+100
| +7% | +$5.93K | ﹤0.01% | 1762 |
|
|
2020
Q3 | $78K | Buy |
1,530
+1,150
| +303% | +$56.3K | ﹤0.01% | 1627 |
|
|
2020
Q2 | $23K | Buy |
+380
| New | +$20.3K | ﹤0.01% | 1755 |
|
Other funds holding DCPH
Nisa Investment Advisors's DCPH Position: Q2 2024 in Review
Nisa Investment Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 23,002 shares — an estimated $362K sold.
Nisa Investment Advisors first reported a position in DCPH in Q2 2020 and held it in 16 quarters. The position peaked at $479K in Q3 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Nisa Investment Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Nisa Investment Advisors sold 23,002 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $362K.
- Nisa Investment Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 16 quarters.
- Nisa Investment Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $479K in Q3 2022.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Nisa Investment Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.